Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia — Stella

Home/Anarthria/Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia

View on ClinicalTrials.gov

Recruiting

Back to Anarthria trials

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

Stanford University School of Medicine, Stanford, California

Massachusetts General Hospital, Boston, Massachusetts

Key details

Sponsor

Leigh R. Hochberg, MD, PhD.

Collaborators

National Institute on Deafness and Other Communication Disorders (NIDCD)

Enrollment target

~3 participants

Started

October 2023

Primary completion

July 2026

Age range

18 Years – 80 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.